Bone Marrow TransplantationTransplantation, AutologousCyclophosphamideBone Marrow PurgingBone MarrowTransplantation, HomologousCombined Modality TherapyWhole-Body IrradiationBone Marrow CellsCarmustineLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsMelphalanGraft vs Host DiseaseEtoposideRemission InductionBusulfanHematopoietic Stem Cell TransplantationTransplantation ConditioningHodgkin DiseaseCytarabineLeukemiaLeukemia, Myeloid, AcuteRecurrenceVincristineTreatment OutcomeHematopoietic Stem CellsColony-Forming Units AssayActuarial AnalysisLeukemia, MyeloidBone and BonesGraft SurvivalBone Marrow DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisSurvival AnalysisPodophyllotoxinAnemia, AplasticDrug EvaluationThiotepaSalvage TherapyLymphomaTime FactorsDisease-Free SurvivalTransplantation ChimeraDoxorubicinLiver TransplantationPrednisoneSurvival RateFollow-Up StudiesTissue DonorsLeukocyte CountGranulocyte Colony-Stimulating FactorAcute DiseaseTransplantation, IsogeneicHistocompatibility TestingStem Cell TransplantationImmunosuppressive AgentsMitoxantroneImmunosuppressionHistocompatibilityAntineoplastic Agents, AlkylatingMesnaLymphatic IrradiationMultiple MyelomaPrognosisMyelodysplastic SyndromesGranulocyte-Macrophage Colony-Stimulating FactorRetrospective StudiesPlatelet CountHepatic Veno-Occlusive DiseaseBlood Cell CountAntibodies, MonoclonalNeuroblastomaMethotrexateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeutropeniaKidney TransplantationT-LymphocytesProspective StudiesCyclosporineGranulocytesHematologic DiseasesGonadal DisordersOvarian Function TestsDrug Administration ScheduleLymphoma, FollicularMice, Inbred C57BLRadiation ChimeraRicinPrednimustineVindesineHematologic NeoplasmsLomustineAgranulocytosisBone Marrow ExaminationThrombocytopeniaGraft RejectionCell SeparationLife Tables